STEVEN GOODMAN: Open Payments
NPI 1447351184 · DELRAY BEACH, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,845 in 140 payments from 20 companies in 2025. Trend: 2023 $2,433 · 2024 $2,631 · 2025 $2,845
Food & beverage: $2,845
| Company | Payments | Amount |
|---|---|---|
| UCB, Inc. | 18 | $524 |
| Amgen Inc. | 19 | $374 |
| ABBVIE INC. | 13 | $302 |
| PFIZER INC. | 21 | $245 |
| Novartis Pharmaceuticals Corporation | 14 | $226 |
| AstraZeneca Pharmaceuticals LP | 9 | $167 |
| E.R. Squibb & Sons, L.L.C. | 9 | $165 |
| Mallinckrodt Hospital Products Inc. | 6 | $148 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 5 | $120 |
| GlaxoSmithKline, LLC. | 5 | $108 |
Products named: Bimzelx, XELJANZ, COSENTYX, SAPHNELO, ORENCIA, EVENITY, ACTHAR, HUMIRA.
Industry payments across FL — which companies pay providers there.
